Optimizing the human perinatal progenitor cell secretome for future paracrine therapy to counteract cardiac disease with AmnioSMART: an ERA4Health-funded project

Eur Heart J. 2024 Nov 7;45(41):4364-4365. doi: 10.1093/eurheartj/ehae550.
No abstract available